- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- monomer
- Ligands
- 1 x ZN: ZINC ION(Non-covalent)
- 11 x OLA: OLEIC ACID(Non-covalent)
- 1 x F7N: [(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-3-propan-2-yl-3-[[3-(trifluoromethyl)-7,8-dihydro-5~{H}-1,6-naphthyridin-6-yl]carbonyl]cyclopentyl]azanium(Non-covalent)
F7N.13: 26 residues within 4Å:- Chain A: V.9, K.10, I.12, G.13, L.16, L.17, Y.21, W.70, S.73, A.74, T.89, Y.92, H.93, N.147, T.151, C.162, G.163, P.164, R.178, Y.282, Q.311, V.312, E.314, T.315, M.318
- Ligands: OLA.7
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:L.17, A:W.70, A:Q.311
- Hydrogen bonds: A:Y.21, A:E.314
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Apel, A.K. et al., Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. Structure (2019)
- Release Date
- 2019-01-02
- Peptides
- C-C chemokine receptor type 2,Rubredoxin,C-C chemokine receptor type 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- monomer
- Ligands
- 1 x ZN: ZINC ION(Non-covalent)
- 11 x OLA: OLEIC ACID(Non-covalent)
- 1 x F7N: [(3~{S},4~{S})-3-methoxyoxan-4-yl]-[(1~{R},3~{S})-3-propan-2-yl-3-[[3-(trifluoromethyl)-7,8-dihydro-5~{H}-1,6-naphthyridin-6-yl]carbonyl]cyclopentyl]azanium(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Apel, A.K. et al., Crystal Structure of CC Chemokine Receptor 2A in Complex with an Orthosteric Antagonist Provides Insights for the Design of Selective Antagonists. Structure (2019)
- Release Date
- 2019-01-02
- Peptides
- C-C chemokine receptor type 2,Rubredoxin,C-C chemokine receptor type 2: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A - Membrane
-
We predict this structure to be a membrane protein.